Stay updated with the latest enzyme news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on enzyme topics.
A major Chinese clinical study on ovarian cancer has been published in CA: A Cancer Journal for Clinicians, one of the world's highest-impact medical journal, marking a first for a Chinese researcher-led gynecological cancer trial, researchers said in Beijing on Sunday. The phase III FZOCUS-1 study tested fluzoparib, a PARP inhibitor developed by Chinese pharmaceutical giant Hengrui Pharma. The trial evaluated the drug as a "maintenance" therapy, treatment given to prevent cancer recurrence aft ...Read More >
BETHESDA, Md. - Gain Therapeutics, Inc. (NASDAQ:GANX), a $69 million market cap biotech company currently trading at $1.92 per share, announced Monday that its lead drug candidate GT-02287 showed encouraging early results in a Phase 1b clinical study for Parkinson's disease patients. According to InvestingPro data, the company maintains a strong balance sheet with more cash than debt, though it's currently experiencing rapid cash burn typical of early-stage biotechs. The company presented inter ...Read More >
A monumental increase of more than 400% in infections from a dangerous drug-resistant bacteria known as New Delhi metallo-beta-lactamase-producing carbapenem-resistant Enterobacterales (NDM-CRE) suggests a growing risk for life-threatening illnesses and deaths with limited treatment options, based on two recent reports. New data in the Annals of Internal Medicine and the CDC's Morbidity and Mortality Weekly Report (MMWR) show spikes in NDM-CRE, a type of gram-negative bacteria often treated wit ...Read More >
Gastroenterologist Dr. Joseph Salhab joins 'Fox & Friends' to examine a new study on the effects of pathogenic gut bacteria and tips for limiting exposure to harmful bacteria. Human infections from drug-resistant bacteria are spiking in the U.S., the Centers for Disease Control and Prevention has warned. The CDC's laboratory tests have shown that occurrences of a bacteria called NDM-producing carbapenem-resistant Enterobacterales (NDM-CRE) have increased dramatically. NDM-CRE belongs to a bro ...Read More >
This advertisement has not loaded yet, but your article continues below. NDM-CRE infections have been historically uncommon in the United States, the CDC said. The NDM gene - which was first identified in 2008 from a Swedish patient who had been hospitalized in New Delhi - creates an enzyme that destroys most antibiotics, including so-called carbapenems, which are usually used in last-ditch efforts to save patients with infections that fail to respond to standard antibiotics, The Washington Pos ...Read More >
Choosing the right vitamin D3 supplement is especially important for vegetarians and vegans, since natural dietary sources are limited. Supplements are essential in maintaining healthy vitamin D levels for bone strength, immunity, and overall vitality. For those following plant-based lifestyles, selecting the correct form of vitamin D3 ensures both nutritional support and alignment with dietary values. It is important to focus on options that provide the same effectiveness as traditional source ...Read More >
Pune - The Leafy Wellness, a nutrition-focused startup, has announced the launch of its plant-based protein powder in India. The product is positioned as an affordable alternative in a market often dominated by premium-priced supplements, and is designed to combine modern plant protein with Ayurvedic ingredients. The demand for plant-based nutrition has grown steadily in India, driven by lifestyle changes, rising fitness awareness, and an increasing preference for vegan and sustainable diets. D ...Read More >
New Delhi, Jul 9 (PTI) Anthem Biosciences on Wednesday fixed a price band of Rs 530 to Rs 570 for its Rs 3,395-crore initial public offering (IPO). At the upper end of the price band, the company's evaluation exceeds Rs 31,800 crore. The initial share-sale will be open for public subscription during July 14-16 and the one-day bidding for anchor investors is scheduled for July 11, the company said. The proposed IPO is entirely an offer-for-sale (OFS) worth Rs 3,395 crore by promoters, investor ...Read More >
Bengaluru: Scientists from Indian Institute of Science (IISc) have developed a simple, glowing paper sensor that could help detect liver cancer early -- using the green glow of a rare earth metal called terbium.The sensor works by detecting an enzyme called "β-glucuronidase", which is found in many living organisms. While it has normal biological roles, high levels of this enzyme are linked to liver cancer, as well as colon, breast, and kidney cancers, and even infections and AIDS."Traditional d ...Read More >
New Delhi, Dec 3 (PTI) Organ damage and death due to severe COVID-19 could be because of disruption to the mitochondria, or a cell's "energy-producing factory", which contributes to 'cytokine storm' -- or excessive inflammation commonly seen in these patients, a new study has found. Researchers found that the damage or stress in mitochondria can trigger immune responses, specifically those that activate the renin-angiotensin-aldosterone system, or 'RAAS', network of hormones, proteins and enzym ...Read More >
It may change your life to begin your day with a spoonful of Neem Tulsi Honey. This powerful combination of Neem, Tulsi, and Honey offers a multitude of benefits, from boosting immunity and aiding digestion to reducing stress and promoting healthy skin. Let's dive into the top 5 benefits of incorporating Neem Tulsi Honey into your morning routine. Boosts immunity: Neem Tulsi Honey has antimicrobial properties that fight infections and boost immunity. Regular consumption prevents a lot of illnes ...Read More >
Stay updated with the latest None news, articles, and insights from trusted sources. Explore in-depth coverage and expert analysis on None topics.